Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Edap Tms S.A. ADR

Start price
Target price
Perf. (%)
€7.00
06.03.24
-
06.03.25
-5.71%
16.03.24

buy
Crossject S.A.

Start price
Target price
Perf. (%)
€4.89
30.12.23
€5.50
30.12.24
-22.39%
10.02.24

Could be worthwhile Investment >10% per year
Carmat

Start price
Target price
Perf. (%)
€7.29
06.12.23
-
06.12.24
-9.60%
09.12.23

buy
Orpea Nom.

Start price
Target price
Perf. (%)
€1.40
09.11.23
-
09.11.24
-27.88%
11.11.23

buy
Sartorius Stedim Biotech S.A.

Start price
Target price
Perf. (%)
€226.00
30.09.23
-
30.09.24
-15.49%
14.10.23

buy
Orpea Nom.

Start price
Target price
Perf. (%)
€1.32
08.09.23
-
08.09.24
10.08%
15.09.23

Could be very worthwhile Investment >20% year
buy
Le Noble Age

Start price
Target price
Perf. (%)
€31.95
30.03.23
-
30.03.24
-37.65%
01.04.24

buy
Bastide Le Confort

Start price
Target price
Perf. (%)
€32.85
07.03.23
-
07.03.24
-45.63%
08.03.24

buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.55
05.03.23
-
05.03.24
-22.78%
02.04.23

buy
Bastide Le Confort

Start price
Target price
Perf. (%)
€31.10
27.02.23
-
27.02.24
-39.81%
28.02.24

buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.58
20.02.23
-
20.02.24
-1.16%
05.03.23

Could be very worthwhile Investment >20% year
buy
Bastide Le Confort

Start price
Target price
Perf. (%)
€32.40
15.02.23
-
15.02.24
-0.77%
06.03.23

Orpea Nom.

Start price
Target price
Perf. (%)
€3.47
10.02.23
-
10.02.24
-43.24%
02.04.23

Orpea Nom.

Start price
Target price
Perf. (%)
€2.40
09.02.23
-
09.02.24
0.71%
21.03.23

buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.17
08.02.23
-
08.02.24
-9.35%
03.04.23

Could be very worthwhile Investment >20% year
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.36
07.02.23
€4.00
07.02.24
9.32%
18.02.23

Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Sartorius Stedim Biotech S.A.

Start price
Target price
Perf. (%)
€345.00
06.02.23
-
06.02.24
-31.36%
07.02.24

Orpea Nom.

Start price
Target price
Perf. (%)
€2.87
05.02.23
-
05.02.24
-10.07%
18.02.23

Could be very worthwhile Investment >20% year
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.87
05.02.23
-
05.02.24
-10.07%
20.02.23

Orpea Nom.

Start price
Target price
Perf. (%)
€2.87
05.02.23
€1.00
05.02.24
-10.07%
18.02.23

buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.82
03.02.23
-
03.02.24
25.04%
10.02.23

buy
Orpea Nom.

Start price
Target price
Perf. (%)
€4.90
02.02.23
-
02.02.24
-41.45%
05.02.23

buy
Orpea Nom.

Start price
Target price
Perf. (%)
€5.54
01.02.23
-
01.02.24
-48.21%
05.02.23

Could be very worthwhile Investment >20% year
buy
Spineway

Start price
Target price
Perf. (%)
€1.01
14.12.22
-
14.12.23
2.97%
24.12.22

Spineway

Start price
Target price
Perf. (%)
€2.20
12.12.22
-
12.12.23
-61.36%
24.04.23

Risky Investment
Growths slower than the competition